Researchers observed a significant disparity in colon cancer mortality related to origin location, independent of confounding variables.
Novel preparation formulation is as effective and safe as current colon prep for colonoscopy. Plus, study participants gave the prep experience a high satisfaction rating.
A very large retrospective study of patients with stage II colon cancer found adjuvant therapy improves survival, regardless of treatment regimen, patient age, or high-risk pathologic risk features.
Adjuvant chemotherapy is associated with improved overall survival in patients with stage II colon cancer regardless of treatment regimen, patient age, or high-risk pathologic risk features.
Consumption of walnuts reduced the growth of colon cancer. Researchers saw a reduction in tumor growth in mice that ate the equivalent of approximately 1 ounce of walnuts a day.
Higher serum levels of 25-hydroxyvitamin D (25(OH)D) correlated with a reduced risk of cancer in women.
Disparities in some cancer mortality rates between African Americans and whites in the United States have decreased, but these differences remain in colorectal and breast cancers.
A methylation signature was identified in 5 types of cancer, and it likely occurs in more. These findings may aid in developing a blood test to diagnose cancer at early stages, when it is most treatable.
Depressive Symptoms Linked to Worse Survival Following Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive SurgeryFebruary 23, 2016
A study examined the relationship between depression and survival for patients undergoing hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery.
The time between a positive fecal blood test result for colon cancer screening and a follow-up colonoscopy varies widely across the United States.
Lack of CDX2 expression identified a subgroup of patients with high-risk stage II colon cancer who seemed to benefit from adjuvant chemotherapy.
Colorectal cancer (CRC) is diagnosed in younger persons in a significantly higher proportion of minority groups in the United States.
There was a statistically significant improvement in knowledge of self-identification and management of hand-foot syndrome.
Fifteen variables independently associated with measure; shows variation in quality among facilities
Some Employment Benefits Are More Helpful in Reducing Financial Burden for Patients With Colorectal CancerJanuary 05, 2016
A survey of patients with stage III colorectal cancer revealed that paid sick leave is associated with a greater likelihood of job retention and reduced personal financial burden. Nearly half of surveyed patients did not retain their jobs, reportedly due to their cancer diagnosis and treatment.
Baseline dietary glutamic acid intake is associated with a lower risk for developing colorectal cancer, particularly in people who are not overweight.
Family members of patients with cancers of unknown primary (CUP) are at higher risk of developing CUP themselves, as well as cancers of the lung, pancreas, and colon and some cancers of the blood.
A biological mechanism counteract colon cancer relapse was identified by a team of Swiss researchers. The approach uses vitamin A to activate a protein that was lost in persisting cancer cells.
Venlafaxine has a significant clinical activity against taxane-oxaliplatin-induced acute neurosensory toxicity in patients with cancer.
All relatives of patients with colorectal cancer are at increased risk for this cancer, regardless of age at diagnosis of the index patient in the family, according to a recent study. These findings may impact guidance regarding screening.
The genetic makeup of colon cancer tumors and survival rates for patients with the disease differ by race, according to a study from the Mayo Clinic Cancer Center in Rochester, Minnesota.
New study data associates the resection of colorectal cancer (CRC) liver metastases with greater risk of postoperative mortality among elderly patients.
Adjuvant chemotherapy does not improve QOL, recurrence, and survival in patients with stage II colon cancerSeptember 10, 2015
Regular consumption of caffeinated coffee may help prevent the return of colon cancer after treatment and improve the chances of a cure, according to a new, large study.
A clinical scoring system for colon cancer risk could help physicians determine which patients require colonoscopies and which could be adequately screened using less invasive methods.
Colonoscopy withdrawal times of 6 minutes or more are associated with lower colon cancer rates.
Patients consuming 4 cups/day of caffeinated coffee have lower recurrence and mortality risk.
An algorithm dubbed ENVE can help clinicians sort through "white noise" and pinpoint genetic aberrations associated with cancer.
The first test that analyzes the sensitivity of tumors to radiation therapy has been developed.
A newly-identified pathway may contribute to the development of colon cancer.
- Ruxolitinib May Improve Symptom Control in Patients With CLL
- 3-drug Regimen With Ricolinostat Active, Safe in Multiple Myeloma
- Lung Cancer Navigator App Aims to Help Patients Understand Disease
- Racial Disparities Persist in Myeloma Treatment Use
- Adding Bortezomib to Rd Improves PFS, OS in Newly Diagnosed Myeloma
- Optimal Timing of Influenza Vaccination in Patients Receiving Chemotherapy
- Racial Disparities Persist in Myeloma Treatment Use
- Hypnosis and Its Use in Cancer Treatment
- Longer Dosing Interval of Zoledronic Acid May Be Acceptable for Bone Metastases
- Patients With Breast Cancer Report More Cognitive Difficulties After Chemotherapy
- Frailty Classifications Associated With Prognosis Among Older Patients
- Beach Umbrella Not Enough for Protection from UV Rays
- Comprehensive Report Looks at Benefits and Harms of Medical Cannabis
- ASCO: Moderate Activity Linked to Longer Survival in Advanced CRC
- MABp1 Improves Symptoms vs Placebo in Colorectal Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|